The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
Croft, S. L., & Coombs, G. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.008 · Cited by 891
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Handbook of Pharmaceutical Controlled Release Technology
Wise, D. L. (2000) · CRC Press eBooks · doi:10.1201/9781482289985 · Cited by 768
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
Specific chemotherapy of Chagas disease: controversies and advances
Urbina, J. A., & Docampo, R. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.001 · Cited by 567
Opportunities and Challenges in Antiparasitic Drug Discovery
Pink, R., Hudson, A., Mouriès, M.-A., & Bendig, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1824 · Cited by 545
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 454
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Cosmetic applications for solid lipid nanoparticles (SLN)
Wissing, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00684-1 · Cited by 364
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Challenges and new discoveries in the treatment of leishmaniasis
Singh, S., & Sivakumar, R. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-004-0348-9 · Cited by 293
Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs
Alving, C. R., Steck, E. A., Chapman, W. L., Waits, V. B., Hendricks, L. D., Swartz, G. M., & Hanson, W. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2959 · Cited by 284
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 250
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib
Joshi, M., & Patravale, V. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600814676 · Cited by 213
Self-citationA novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles
Wissing, S. A., & Müller, R. H. (2001) · International Journal of Cosmetic Science · doi:10.1046/j.1467-2494.2001.00087.x · Cited by 182
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA
Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R. H., & Kneuer, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00506-5 · Cited by 181
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Dubes, A., Parrot-Lopez, H., Abdelwahed, W., Degobert, G., Fessi, H., Shahgaldian, P., & Coleman, A. W. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00020-1 · Cited by 174
Yardley, V., & Croft, S. L. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00133-8 · Cited by 163
Shahgaldian, P., Da Silva, E., Coleman, A. W., Rather, B., & Zaworotko, M. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00639-7 · Cited by 158
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Tuftsin-bearing liposomes in treatment of macrophage-based infections
Agrawal, A. K., & Gupta, C. M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00061-7 · Cited by 135
Medda, S., Mukhopadhyay, S., & Basu, M. K. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.6.791 · Cited by 130
Gessner, A., Olbrich, C., Schröder, W., Kayser, O., & Müller, R. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00639-6 · Cited by 127
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
Koziara, J. M., Oh, J. J., Akers, W. S., Ferraris, S. P., & Mumper, R. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7547-7 · Cited by 125
Lutwyche, P., Cordeiro, C., Wiseman, D. J., St-Louis, M., Uh, M., Hope, M. J., Webb, M. S., & Finlay, B. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2511 · Cited by 121
Hien, T. T., Davis, T. M. E., Chuong, L. V., Ilett, K. F., Sinh, D. X. T., Phu, N. H., Agus, C., Chiswell, G. M., White, N. J., & Farrar, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4234-4239.2004 · Cited by 118
Liposomes and Nanoparticles in the Treatment of Intracellular Bacterial Infections
Couvreur, P., Fattal, E., & Andremont, A. (1991) · Pharmaceutical Research · doi:10.1023/a:1015885814417 · Cited by 117
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 117
Tempone, A. G., Perez, D., Rath, S., Vilarinho, A. L., Mortara, R. A., & de Andrade, H. F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh281 · Cited by 112
Mosqueira, V. C. F., Loiseau, P. M., Bories, C., Legrand, P., Devissaguet, J., & BARRATT, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1222-1228.2004 · Cited by 109
Owais, M., Varshney, G. C., Choudhury, A., Chandra, S., & Gupta, C. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.180 · Cited by 104
Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles
Bocca, C., Caputo, O., Cavalli, R., Gabriel, L., Miglietta, A., & Gasco, M. R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00282-8 · Cited by 99
Heydenreich, A. V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00688-9 · Cited by 98
Harmine: Evaluation of its Antileishmanial Properties in Various Vesicular Delivery Systems
Lala, S., Pramanick, S., Mukhopadhyay, S., Bandyopadhyay, S. K., & Basu, M. K. (2004) · Journal of drug targeting · doi:10.1080/10611860410001712696 · Cited by 97
Olbrich, C., Gessner, A., Schröder, W., Kayser, O., & Müller, R. H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.024 · Cited by 95
Coukell, A. J., & Brogden, R. N. (1998) · Drugs · doi:10.2165/00003495-199855040-00008 · Cited by 95
Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug
Alving, C. R., Steck, E. A., Hanson, W. L., Loizeaux, P. S., Chapman, W. L., & Waits, V. B. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90270-9 · Cited by 94
The transferrin receptor of Trypanosoma brucei
Steverding, D. (2000) · Parasitology International · doi:10.1016/s1383-5769(99)00018-5 · Cited by 81 · cited 1×
“B io lo gi ca l as pe ct s of m al ar ia , le is hm an ia si s an d tr yp an os om ia si s [1 ,6 – 9]”
BackgroundDrug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes
Banerjee, G., NANDI, G., Mahato, S. B., Pakrashi, A., & Basu, M. K. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.1.145 · Cited by 81
Longmuir, K. J., Robertson, R. T., Haynes, S. M., Baratta, J. L., & Waring, A. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9609-x · Cited by 80
Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla, S., & Dingler, A. (2001) · PubMed · Cited by 78
Chimanuka, B., Gabriëls, M., Detaevernier, M. R., & Plaizier-vercammen, J. A. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(01)00611-2 · Cited by 77
Alving, C. R., Steck, E. A., Chapman, W. L., Waits, V. B., Hendricks, L. D., Swartz, G. M., & Hanson, W. L. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90207-6 · Cited by 75
Kole, L., Das, L., & Das, P. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314929 · Cited by 75
Physical and chemical evaluation of liposomes, containing artesunate
Gabriëls, M., & Plaizier-vercammen, J. A. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00678-7 · Cited by 72
Macrophage Specific Drug Delivery in Experimental Leishmaniasis
Basu, M. K., & Lala, S. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360186 · Cited by 71
Tyagi, R., Lala, S., Verma, A. K., Nandy, A. K., Mahato, S. B., Maitra, A., & Basu, M. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500046732 · Cited by 70
Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles
Föger, F., Noonpakdee, W., Loretz, B., Joojuntr, S., Salvenmoser, W., Thaler, M., & Bernkop‐Schnürch, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.034 · Cited by 66
Torres-Santos, E. C., Júnior, J. M. R., Moreira, D. D. L., Kaplan, M. A. C., & Rossi‐Bergmann, B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1776 · Cited by 66
Gaspar, R. S., Véronique Préat, A., Opperdoes, F. R., & Roland, M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015807706530 · Cited by 64
Sarkar, S., Mandal, S., Sinha, J., Mukhopadhyay, S., Das, N., & Basu, M. K. (2002) · Journal of drug targeting · doi:10.1080/106118021000072681 · Cited by 64
Solid lipid nanoparticles as drug carriers
Heiati, H., TAWASHI, R., & Phillips, N. C. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00236-1 · Cited by 63
Targeted Drug Delivery to Macrophages in Parasitic Infections
Owais, M., & Gupta, C. M. (2005) · Current Drug Delivery · doi:10.2174/156720105774370177 · Cited by 62
González-Martin, G., Merino, I. G., Rodríguez-Cabezas, M. N., Torres, M., Nuáez, R., & Osuna, A. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb03301.x · Cited by 57
Molina, J., Urbina, J., Gref, R., Brener, Z., & Rodrigues Júnior, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.101 · Cited by 57
Jm, R., Croft, S. L., Fessi, H., Bories, C., & Devissaguet, J. P. (1994) · PubMed · Cited by 54
Subverted transferrin trafficking in Leishmania- infected macrophages
Borges, V. M., Vannier-Santos, M. A., & de Souza, W. (1998) · Parasitology Research · doi:10.1007/s004360050493 · Cited by 52
Delivery of antimicrobials to infected tissue macrophages
Bakker‐Woudenberg, I. A. J. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00037-8 · Cited by 51
Cruz, M. T., Gaspar, R. S., Donato, A., & Lopes, M. C. (1997) · Pharmaceutical Research · doi:10.1023/a:1012059501947 · Cited by 51
Lipid-based amphotericin B formulations: from animals to man
Bekersky, I., Fielding, R. M., Buell, D. N., & Lawrence, I. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00160-1 · Cited by 50
Bacopasaponin C: Critical Evaluation of Anti-Leishmanial Properties in Various Delivery Modes
Sinha, J., Raay, B., Das, N., Medda, S., Garai, S., Mahato, S. B., & Basu, M. K. (2002) · Drug Delivery · doi:10.1080/107175402753413181 · Cited by 49
Risovic, V., Boyd, M. C., Choo, E., & Wasan, K. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3339-3342.2003 · Cited by 48
Yardley, V., & Croft, S. L. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.193 · Cited by 46
Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations
Papagiannaros, A., Bories, C., Demetzos, C., & Loiseau, P. M. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.06.011 · Cited by 46
Olbrich, C., Schöler, N., Tabatt, K., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023754 · Cited by 44
A Novel Peptide-Grafted Liposomal Delivery System Targeted to Macrophages
Banerjee, G., Medda, S., & Basu, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.348 · Cited by 43
In vivo evaluation of arteether liposomes
Bayomi, M. A., Al-Angary, A. A., Al‐Meshal, M. A., et al. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00182-3 · Cited by 38
Schöler, N., Zimmermann, E., Katzfey, U., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00430-5 · Cited by 35
Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Parasitic Infections
Edwards, G., & Krishna, S. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1113-9 · Cited by 34
Tachibana, H., Yoshihara, E., Kaneda, Y., & Nakae, T. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.966 · Cited by 33
Delivery strategies for antiparasitics
Kayser, O., & Kiderlen, A. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.197 · Cited by 32
Postma, N. S., Crommelin, D. J. A., Eling, W. M. C., et al. (1999) · PubMed · Cited by 32
Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam
New, R. R. C., & Chance, M. L. (1980) · PubMed · doi:10.5169/seals-312657 · Cited by 26
Ligation of Fc receptor of macrophages stimulates protein kinase C and antileishmanial activity
Daasgupta, D., Chakraborty, P., & Basu, M. K. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007051413280 · Cited by 25
Kole, L., Sarkar, K., Mahato, S. B., & Das, P. K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1455 · Cited by 25
Schöler, E. Z. N. (2000) · Journal of Microencapsulation · doi:10.1080/026520400417685 · Cited by 24
Chakraborty, R., Dasgupta, D., Adhya, S., & Basu, M. K. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400393 · Cited by 21
Crommelin, D. J. A., Eling, W. M. C., Steerenberg, P. A., Nässander, U. K., Storm, G., de Jong, W. H., van Hoesel, Q. G. C. M., & Zuidema, J. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90038-f · Cited by 17
Drug-laden liposomes in antitumor therapy and in the treatment of parasitic diseases
Crommelin, D. J. A., Nässander, U. K., Peeters, P. A. M., et al. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90136-h · Cited by 9
Ktenate nanoparticles (bdellosomes): a novel strategy for delivering drugs to parasites or tumours
Flaig, R. M., Rosenkranz, V., Wink, M., & Fricker, G. (2005) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(05)50007-8 · Cited by 4
Cited by
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Self-citationBhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazú, V., Borm, P., Estrada, G., Ntziachristos, V., & Razansky, D. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-3 · Cited by 495
Gene therapy and DNA delivery systems
Ibraheem, D., Elaissari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.041 · Cited by 454
Metadata
- Authors
- DATE, A., JOSHI, M., & PATRAVALE, V
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07-10
- Volume
- 59
- Issue
- 6
- Pages
- 505-521
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2065817859
- Cited by
- 293
- References
- 96
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.